---
title: "Emerson EMR tops Q4 estimates as orders build a backlog for 2027"
canonical_url: https://www.stockexpertai.com/journal/2026-11-04/emerson-emr-tops-q4-estimates-as-orders-build-a-backlog-for-2027-dfb215452bb3
last_updated: 2026-11-05T04:07:54.431Z
section: "Earnings Watch"
author: "Stock Expert AI Research"
publisher: Stock Expert AI
tickers: EMR
content_type: journal-article
---

# Emerson EMR tops Q4 estimates as orders build a backlog for 2027

_Emerson's fiscal fourth-quarter sales and adjusted EPS beat analyst estimates, and management pointed to strong orders even as Europe and China stay weak._

![EMR — Journal cover](/public-objects/streetnews/2026-11-04/EARNINGS_WATCH-cover-4ce5f4c9.jpg)
Stock Expert AI data cover: figures from Financial Modeling Prep.
Photo credit and licence on the image

Emerson Electric (EMR) reported adjusted earnings per share (EPS) of 1.86 for the fiscal fourth quarter ended Sept. 30, 2026, against an analyst estimate of 1.85. Revenue was $5.20B against an estimate of $5.11B, and above the $4.86B reported in the year-ago quarter. The beat is small. The more important story is management's account of strong orders and a growing backlog, which it says supports its fiscal 2027 plan. Figures are current as of Nov. 4, 2026.

## Key facts

- **Nov. 4, 2026, EPS:** adjusted EPS was 1.86 vs an analyst estimate of 1.85 (difference +$0.01) for the quarter ended Sept. 30, 2026.
- **Nov. 4, 2026, revenue:** $5.20B vs an analyst estimate of $5.11B (difference +$91.7M). Revenue was up 7.1% from $4.86B in the quarter ended Sept. 30, 2025.
- **Year-ago comparison:** net income was $744.0M vs $636.0M a year earlier (up 17.0%). Diluted EPS under standard accounting rules (GAAP) was 1.33 vs 1.12.
- **Cash:** free cash flow (cash left after capital spending) was $917.0M in the quarter vs $842.0M a year earlier.
- **Stock:** shares were 170.44 USD on Nov. 4, 2026, up 2.43% on the latest quote. The 52-week range is 122.64-172 USD.

| Metric (quarter ended Sept. 30, 2026) | Latest | Year-ago or estimate |
|---|---|---|
| Adjusted EPS | 1.86 | Estimate 1.85 |
| Revenue | $5.20B | Estimate $5.11B; year-ago $4.86B |
| Operating income | $1.07B | Year-ago $982.0M |
| Net income | $744.0M | Year-ago $636.0M |
| Diluted EPS (GAAP) | 1.33 | Year-ago 1.12 |

Note: the 1.86 figure is an adjusted number that excludes items such as amortization of acquired intangibles and restructuring costs. The 1.33 figure includes them. The company's own adjusted figure is the one compared with the analyst estimate.

## What happened

Emerson makes automation hardware and software for factories, power plants, energy facilities and similar customers. In its release, the company said fourth-quarter sales and profitability exceeded its expectations. CEO Surendralal "Lal" Karsanbhai said: "Customers are investing in automation at a rapid pace. And our orders reflect it."

Management said underlying orders (orders excluding currency effects and big deals, and not counting AspenTech) grew 14% in the quarter. It described demand as broad-based, with strength in long-cycle projects in power, liquefied natural gas (LNG), and aerospace and defense. It also said its "growth verticals," the areas it is steering toward, now make up a larger share of sales, led by LNG, semiconductor and power customers.

The Software and Systems group was the standout. Management said underlying sales there rose 14% in the quarter, and its margin improved on higher volume, better price-versus-cost and a richer mix. For scale, the most recent segment data in our feed is for the third quarter ended June 30, 2026: Intelligent Devices revenue was $2.68B, Software And Systems revenue was $1.64B, and Final Control revenue was $552.0M. By region that quarter, the Americas were $2.54B, Asia, Middle East & Africa $1.48B, and Europe $861.0M.

### The five-quarter trend

This table shows margins and cash flow improving together as sales climbed from the seasonally weaker winter quarter.

| Quarter ended | Revenue | Gross margin | Operating margin | Free cash flow |
|---|---|---|---|---|
| Sept. 30, 2025 | $4.86B | 51.9% | 20.2% | $842.0M |
| Dec. 31, 2025 | $4.35B | 53.2% | 19.9% | $602.0M |
| March 31, 2026 | $4.56B | 53.1% | 19.8% | $694.0M |
| June 30, 2026 | $4.87B | 54.5% | 20.5% | $1.32B |
| Sept. 30, 2026 | $5.20B | 52.7% | 20.6% | $917.0M |

What changed: operating margin (operating income as a share of sales) edged up to 20.6%, the highest of the five quarters. Gross margin slipped from 54.5% in the June quarter to 52.7%, though it was still higher than the year-ago 51.9%. Free cash flow was lower than the June quarter, when operating cash flow was $1.42B vs $1.08B in the latest quarter, and capital spending rose to $159.0M from $102.0M.

Capital return also shifted. Buybacks were $102.0M in the latest quarter vs $356.0M in the June quarter, while dividends stayed near $309.0M. The company also raised its quarterly dividend, according to its release.

### Cost pressure in the quarter

On the call, Andrew Obin of BofA asked about a corporate expense overrun in the quarter. CFO Michael J. Baughman called it several individually small items, including a medical claims miss and an impairment (a write-down of an asset's value). He said it should not repeat in 2027, but flagged some added spending on digital enablement.

## Why it matters for investors

**The outlook.** For fiscal 2027, management guided to underlying sales growth in the mid-single digits, a higher adjusted segment EBITDA margin than in 2026, higher adjusted EPS and higher free cash flow, and a large capital return split between buybacks and dividends. It also assumed modest price increases. For the first quarter of fiscal 2027, the company's adjusted EPS guidance is $1.58 to $1.62, which brackets the analyst estimate of 1.61 for the quarter, and revenue is estimated at $4.60B (next report expected 2027-02-02). Baughman said the orders and backlog "give us confidence in achieving 2027 results that are right in line with our 2028 targets."

Scott Davis of Melius asked whether the guide looked conservative given the strength in orders and backlog. Management pointed to accelerating orders and backlog in its growth verticals, and named Europe and China as the reasons for caution.

**Valuation vs peers.** On a trailing 12-month basis, Emerson trades at a price-to-earnings (P/E) ratio of 35.57, with a net margin of 14.1%. Here is how peers compare:

| Company | Market cap | P/E (trailing) | Net margin |
|---|---|---|---|
| Emerson (EMR) | $95.07B | 35.57 | 14.1% |
| ABB Ltd (ABBNY) | $156.55B | 31.37 | 13.5% |
| Dover (DOV) | $28.29B | 24.64 | 13.6% |
| Eaton (ETN) | $137.14B | 35.20 | 12.2% |
| IDEX (IEX) | $17.17B | 32.37 | 14.6% |

Emerson's P/E is the highest in this group, slightly above Eaton's, and its net margin is higher than ABB, Dover and Eaton but lower than IDEX. Other trailing measures: price-to-sales 5.01, enterprise value to EBITDA 19.72, price to free cash flow 26.89, and a dividend yield of 1.3%.

**Analysts.** The consensus price target is an average of 167.18 USD (median 171.00 USD, high 186.00 USD, low 135.00 USD). The latest share price of 170.44 USD sits above the average target. Of 43 ratings, 23 are buy, 17 are hold and 3 are sell, for a consensus of "Buy." Morgan Stanley reiterated an Underweight rating on 2026-11-03. Our feed shows 0 open-market insider purchases or sales in the last 90 days, though older filings may be missing.

**Our MoonshotScore.** Stock Expert AI's MoonshotScore V2 for EMR is 69.1 (Strong). Sector-relative pillars: momentum 82, quality 77, safety 63, growth 48 and valuation 33. In plain terms, the stock's price trend and business quality screen well, while growth and valuation are the weak spots. That fits the data above: sales growth is steady rather than fast, and the P/E is high.

**Balance sheet.** At Sept. 30, 2026, Emerson held $1.81B in cash and short-term investments against $12.18B of total debt, leaving net debt of $10.37B and shareholders' equity of $20.74B. Debt-to-equity is 0.59. Financial-strength scores are healthy: Piotroski 9 on a 0-9 scale and Altman Z 3.47.

## Risks and what could go wrong

Management named several headwinds:

- **Europe:** industrial markets in Germany, France and Italy are weak, and management does not expect an inflection.
- **China:** weakness in chemicals and refining persists, and the plan does not assume a recovery.
- **Middle East:** conflict reduced fiscal 2026 revenue, and the 2027 outlook assumes no escalation.
- **Semiconductors:** management modeled a slowdown in the second half of 2027 as a cautious assumption.
- **Inflation:** material cost increases are modeled in electronics, and memory-related pricing will be unfavorable.
- **First-half margins:** startup costs for an expansion, mainly in Intelligent Devices, will weigh on margins early in the year.

Valuation is the other risk. A P/E of 35.57 and a valuation pillar score of 33 mean expectations are already high, and our own FMP-sourced discounted cash flow model estimate is 97.75 USD per share, well below the current price. Models like this depend heavily on assumptions, so treat it as one input.

## What to watch next

- **Next report:** expected 2027-02-02, with an analyst EPS estimate of 1.61 and a revenue estimate of $4.60B.
- **Orders and backlog:** whether the strong order growth turns into sales in the long-cycle projects.
- **Buyback pace:** management front-loaded repurchases to lower the share count and keep room for bolt-on acquisitions. If no deal appears, it said the rest would be spread across the later months.
- **Europe and China:** any sign these regions stop dragging on Intelligent Devices.
- **Margins:** whether startup costs and the corporate expense items stay contained.

## Frequently asked questions

## Q: Did Emerson beat earnings estimates in fiscal Q4 2026?

Yes, narrowly. For the quarter ended Sept. 30, 2026, adjusted EPS was 1.86 vs an analyst estimate of 1.85, and revenue was $5.20B vs an estimate of $5.11B. Revenue was also higher than the $4.86B a year earlier.

## Q: What did Emerson say about its 2027 outlook?

Emerson said it expects mid-single-digit underlying sales growth, a higher adjusted margin, higher adjusted EPS and higher free cash flow in fiscal 2027, according to its release and call. It guided first-quarter adjusted EPS to $1.58 to $1.62. The CFO said backlog and orders support the plan.

## Q: Is Emerson stock expensive compared with peers?

On trailing earnings, Emerson's P/E of 35.57 is the highest among ABB (31.37), Dover (24.64), Eaton (35.20) and IDEX (32.37). Its net margin of 14.1% is higher than three of those four peers. Our MoonshotScore valuation pillar is 33, the weakest of its five pillars. This describes how the stock is priced, not a recommendation.

*Sources: Stock Expert AI market data (MoonshotScore, valuation and cash flow figures from FMP); company statements from Emerson's Nov. 4, 2026 release and earnings call; analyst data from FMP consensus. Third-party reports are not used for figures.*

*This is educational content, not investment advice. Past performance does not guarantee future results.*

## Related Tickers
- [EMR](https://www.stockexpertai.com/stock/emr)

## Sources
- [Stock Expert AI EMR page: quote, financials and MoonshotScore](https://www.stockexpertai.com/stock/emr)
- [prnewswire.com: Emerson Reports Fourth Quarter and Full Year 2026 Results; Provides Initial 2027 Outlook](https://www.prnewswire.com/news-releases/emerson-reports-fourth-quarter-and-full-year-2026-results-provides-initial-2027-outlook-302928622.html)
- [seekingalpha.com: Emerson Electric Co. (EMR) Q4 2026 Earnings Call Transcript](https://seekingalpha.com/article/4962237-emerson-electric-co-emr-q4-2026-earnings-call-transcript)
- [zacks.com: EMR Q4 Earnings Beat on Software & Systems Strength](https://www.zacks.com/stock/news/3023151/emr-q4-earnings-beat-on-software-systems-strength?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-3023151)
- [zacks.com: Compared to Estimates, Emerson Electric (EMR) Q4 Earnings: A Look at Key Metrics](https://www.zacks.com/stock/news/3022843/compared-to-estimates-emerson-electric-emr-q4-earnings-a-look-at-key-metrics?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm-3022843)
- [zacks.com: Emerson Electric (EMR) Beats Q4 Earnings and Revenue Estimates](https://www.zacks.com/stock/news/3022680/emerson-electric-emr-beats-q4-earnings-and-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-3022680)

---
_Written by Stock Expert AI's research desk with AI assistance. Figures come from FMP data and the official sources cited in the article. Educational research, not financial advice._